Ann: Biotron to Present Positive 48 Week Data fro, page-7

re: Ann: Biotron to Present Positive 48 Week ... Folks,

The facts are:

at 3 months 7 of 8 who had 400mg achieved svr.
At 1 year, 8 of 8.

Compare with just SOC, 65% at 3 months to 75% at 1 year i.e 6 out of 8.

Effectively,a 25% improvement from rib/int SOC. Good if other things being equal.

Now, read todays article in fiercebiotech about Abbott's recent success in phase 2b trial.

http://www.fiercebiotech.com/story/abbotts-interferon-free-hep-c-combo-wows-phiib-test/2012-10-15?utm_medium=nl&utm_source=internal


It makes biotron news seem insignificant and outdated.

My feeling is that bit225's success will be based solely on its success with HIV.